Linc AB invests in product oriented companies in the Nordic Life Science industry.
Business Model:
Revenue: $0
Employees: 0-0
Address: Strandvägen 7A
City: Stockholm
State: stockholms län
Zip: 114 51
Country: SE
Linc AB invests in product oriented companies in the Nordic Life Science industry. Linc AB mainly invest in and develop small and medium-sized product oriented life science companies in Medical Technology and Pharmaceuticals.
Contact Phone:
Contact Email:
Listed Exchange:
STO
IPO Date:
5/18/2021
IPO Valuation:
$145M
Ticker Symbol:
LINC
IPO Price:
$8.811496854838799/share
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2022 | FluoGuide | Post-IPO Equity | 0 |
7/2020 | Gesynta Pharma | Series C | 0 |
11/2020 | OncoZenge | Venture Round | 1.2M |
4/2022 | Initiator Pharma | Secondary Market | 2.1M |
5/2022 | Cinclus Pharma | Venture Round | 0 |
12/2021 | Oncorena | Venture Round | 0 |
5/2022 | Cinclus Pharma | Venture Round | 0 |
3/2022 | FluoGuide | Post-IPO Equity | 0 |
12/2021 | Oncorena | Venture Round | 0 |
7/2020 | Gesynta Pharma | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|